Position in BLLN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$22,351,070
-$9,726,771 QoQ
Shares Held
283,140
-27.8% QoQ
Ownership
0.616%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $13,317,692,725 across 38 Diagnostics & Research names. BLLN ranks #16 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
6,795,482 | $3,340,183,256 | |
| 2 | DHR |
Danaher Corp /De/
|
16,917,649 | $3,207,586,242 | |
| 3 | NTRA |
Natera, Inc.
|
13,386,667 | $2,677,199,525 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
5,407,690 | $922,227,443 | |
| 5 | DGX |
Quest Diagnostics Inc
|
3,846,456 | $753,828,439 | |
| 6 | WAT |
Waters Corp /De/
|
1,973,648 | $587,752,368 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
779,882 | $438,207,890 | |
| 8 | LH |
Labcorp Holdings Inc.
|
1,532,723 | $408,945,815 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,351,070 | 283,140 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $32,077,841 | 391,958 | Shares | Defined | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||